Topics
News
CME/CE
Editorial Advisory Board
Partnerships
Mohs surgery more cost-effective for facial nonmelanoma skin cancers
Providence, R.I. - Mohs surgery appears to be a more cost-effective strategy for the treatment of facial nonmelanoma skin cancers (NMSCs) compared with traditional surgical excision, although the advantage of Mohs surgery is sensitive to the type of repair performed, according to the results of a study presented by Tracy L. Bialy, M.D., M.P.H., at the annual meeting of the Society for Investigative Dermatology
Related Videos
Related Content
The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice
February 18th 2021
The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice
February 18th 2021
